February 6, 2016
UT Conference Center
Directly provided by the UT Graduate School of Medicine and the Department of Medicine
This course is designed for physicians who specifically treat Hematologic Oncology patients. Physician assistants, nurse practitioners, nurses and pharmacists are also welcome to participate.
At the conclusion of this program the participant should be able to summarize current and ongoing study results in patients with hemostasis/thrombosis, multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia and malignant lymphoma and optimize new drug therapies for these specific cancer patients.
Early Registration (through January 22, 2016)
Registration (after January 22, 2016)
1) Register Now Online
Attendees may register online through the University of Tennessee Conference Center. Register Now
Download the UT Conference Center map or contact our office 865-305-9190 for assistance. Download Map
The University of Tennessee College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Tennessee College of Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based program will provide a statement for five (5.0) live contact hours credit (0.5 CEUs) and will be mailed within 3 weeks following the program. Successful completion includes attending the session, signing the attendance sheet, and completion of the program evaluation form. UAN: 0064-9999-16-006-L01-P
NABP e-PROFILE ID NUMBER: Your CE credits will also be submitted electronically to NABP. Pharmacists or pharmacy technicians with questions regarding their NABP e-Profile or CPE Monitor should refer to the FAQ section on the NABP website: www.nabp.net/programs/cpe-monitor/cpemonitor-service. To receive credit for your participation in this course, all pharmacists must include their NABP e-Profile ID number, along with their date and month of birth. If incorrect information is provided, this will result in “rejected” status from the CPE Monitor. It is the responsibility of the participant to notify The University of Tennessee (within the 60 day submission timeframe) of their corrected information. Otherwise, the completed CE will not be accepted by the CPE Monitor.
Grievance Policy: A participant, provider, faculty member or other individual wanting to file a grievance with respect to any aspect of a program provided or co-provided by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
Tweets by @utgsm
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2016